Lithium citrate

Lithium citrate is a lithium supplement that reduces excess brain N-acetylaspartate (NAA) in Canavan disease. Canavan disease is an autosomal recessive leukodystrophy caused by mutations in the aspartate acylase (ASPA) gene, which catalyzes the hydrolysis of N-acetylaspartate (NAA) to acetate and aspartate[1].

Product Specifications

CAS Number

[919-16-4]

Product Name Alternative

Litarex

UNSPSC

12352211

Hazard Statement

H302, H315, H319, H335

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/lithium-citrate.html

Purity

98.0

Solubility

10 mM in DMSO

Smiles

O=C(CC(C(O[Li])=O)(CC(O[Li])=O)O)O[Li]

Molecular Formula

C6H5Li3O7

Molecular Weight

209.92

Precautions

H302, H315, H319, H335

References & Citations

[1]Mitra Assadi, et al. Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease. Eur J Paediatr Neurol. 2010 Jul;14 (4) :354-9.